Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia. [electronic resource]
- Clinical cancer research : an official journal of the American Association for Cancer Research Jan 2012
- 487-98 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-3265
10.1158/1078-0432.CCR-11-1440 doi
Adult Aged Aged, 80 and over Animals Antineoplastic Agents--pharmacology Biphenyl Compounds--pharmacology CD40 Antigens--metabolism CD40 Ligand--metabolism Coculture Techniques Dasatinib Drug Resistance, Neoplasm Drug Synergism Gene Expression Humans Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy Lymph Nodes--pathology Mice Middle Aged Minor Histocompatibility Antigens Myeloid Cell Leukemia Sequence 1 Protein NF-kappa B--metabolism NIH 3T3 Cells Nitrophenols--pharmacology Piperazines--pharmacology Proto-Oncogene Proteins c-bcl-2--genetics Pyrimidines--pharmacology Signal Transduction Sulfonamides--pharmacology Thiazoles--pharmacology Tumor Cells, Cultured--drug effects Vidarabine--analogs & derivatives p38 Mitogen-Activated Protein Kinases--metabolism